Company Filing History:
1 out of 3 
1 out of 176 
Years Active: 2013
Title: The Innovative Mind of Pascal Derkinderen
Introduction
Pascal Derkinderen is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. His innovative approach has led to the development of a unique method that could potentially change the landscape of therapeutic interventions for this debilitating condition.
Latest Patents
Pascal holds a patent for a method of screening for inhibitors of tau protein phosphorylation by tyrosine kinase c-Abl. This invention provides methods of screening for candidate compounds that are useful in treating Alzheimer's disease and related conditions by inhibiting specific phosphorylation of tau protein by tyrosine kinase c-Abl. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Pascal has worked with esteemed organizations such as Proteome Sciences Plc and King's College London. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities and impact.
Collaborations
Pascal has had the opportunity to work alongside talented individuals, including Malcolm Andrew Ward and Helen Louise Byers. These collaborations have enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Pascal Derkinderen's work exemplifies the spirit of innovation in medical research. His contributions, particularly in the area of Alzheimer's disease treatment, highlight the importance of continued research and development in this critical field.